Ian Shakil, CHIEF STRATEGY OFFICER at Augmedix, Inc. (AUGX), sold 39,088 shares at $3.82 ($149K) on 2024-04-12, disclosed to the SEC on 2024-04-15.
Scheduled sale ($149k) by CHIEF STRATEGY OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.82 | 19,544 | $75K | 50.0% |
| 2 | $3.82 | 19,544 | $75K | 50.0% |
| Total | $3.82 avg | 39,088 | $149K | 100% |
| Filing → |
| AUGX | SELL | 2024-04-11 | $738K | — | Filing → |
| AUGX | SELL | 2024-04-09 | $678K | — | Filing → |
| AUGX | SELL | 2024-04-09 | $260K | — | Filing → |